What next for the vaccine makers as AstraZeneca ends its Covid jab? – The Times

In May 2020, Catherine Green gained a new lab partner. The chatty Oxford University scientist had spent four months working 18-hour days trying to develop a vaccine for Covid, which was ripping through the population and crippling the economy with a devastating lockdown.

Then the FTSE 100 pharma company AstraZeneca came calling. The company offered to use its heft to scale up and manufacture the promising jab that Green and her colleagues had developed.

It was initially a frosty marriage. We felt a bit of trepidation that teaming up with a pharmaceutical giant would mean someone else making large profits off the back of our efforts, Green recalled in her book Vaxxers, co-written with Sarah Gilbert, professor of vaccinology at Oxford University. A dejected Green

Continue reading here:

What next for the vaccine makers as AstraZeneca ends its Covid jab? - The Times